Quan Capital is an institutional investor (Conventional VCs) founded in 2017 and headquartered in Pudong, China. We are Company Builders Identifying, incubating and growing future industry leaders in life sciences. We are Industry Veterans Capturing evolving healthcare trends and emerging cutting-edge innovations We are Preferred Partners Connecting companies with extensive network and resources globally and in China Windward Bio Doses First Patients in Phase 2 SIRIUS COPD Study of Ultra Long- Acting Anti-TSLP Antibody WIN378. June 8, 2026 China NMPA Grants IND Clearance to Adcentrx Therapeutics’ ADRX-0405 STEAP1 ADC for the Treatment of Late-Stage Solid Tumors, Including Prostate Cancer. Venture capital firm focused on early and growth stage companies.

Stage

Growth, Growth

HQ

Pudong, china

Founded

2017

Website

https://www.quancapital.com/en/

LinkedIn

https://linkedin.com/company/quancapital

Preparing to pitch Quan Capital?

CrackTheDeck analyzes your pitch deck before the meeting — structure, narrative, investor fit.